Julia Moore Vogel and Danilo Buonsenso on long COVID
The Lancet Infectious Diseases in conversation with
00:00
Why clinical trials in long COVID struggle
Julia Moore Vogel outlines trial challenges: heterogeneity, outcome measures, small sample sizes and barriers for housebound patients.
Play episode from 11:59
Transcript
